article thumbnail

Nevro’s AI-Based Spinal Cord Stimulation Device for Chronic Pain Receives FDA Approval

XTalks

Global medical device company Nevro Corp has received US Food and Drug Administration (FDA) approval for the Senza HFX iQ spinal cord stimulation (SCS) system for the treatment of long-term or chronic pain. HFX iQ is designed to improve the consistency of pain relief and is the only SCS system that truly personalizes care,” said D.

article thumbnail

Data dive finds cheap diuretic could be Alzheimer’s drug

pharmaphorum

Bumetanide’s potential was discovered by analysing data on more than 1,300 FDA-approved drugs derived from brain tissue samples, laboratory experiments involving animal and human cells, and human population studies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

His research focuses on the development of big data machine learning for tracking the health of complex systems. He has worked on Visensia, the world’s first FDA-approved multivariate patient monitoring system, and the SEND system, which is now used to monitor 20,000 patients each month in the NHS.

article thumbnail

The future of AI drug discovery & development in immunology and GPCR research

pharmaphorum

The companies hope that in the year to come those data targets will be entered for validation, hit generation, and lead selection. AI relies on data. Speed and cost-effectiveness are one thing, but without good data to act upon, results are meaningless. AI drug discovery in immunology today, and tomorrow.

article thumbnail

Top 10 Largest Publicly Traded Medical Device Companies by Market Cap in 2024

XTalks

Additionally, BD received FDA approval for self-collection of cervical cancer screening samples and joined forces with Quest Diagnostics to develop companion diagnostics for personalized medicine. Alcon (ALC) Market Capitalization: $62.6 Mindray (300760.SZ) SZ) Market Capitalization: $55.9

Marketing 105
article thumbnail

Artificial intelligence could be new blueprint for precision drug discovery

The Pharma Data

online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval. “Academic labs and pharmaceutical and? biotech companies?have

Drugs 52
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

Paxlovid was first authorized under the FDA Emergency Use Authorization in December 2021 ; however, it has received FDA approval on May 25, 2023. pneumoniae serotypes) replaced the company’s first pneumococcal conjugate vaccine Prevnar (PCV7, approved by the FDA in February 2000) in a February 2010 FDA approval.

Sales 98